An alternative synthesis of Azilsartan: an angiotensin II receptor blocker

This paper provides a description of an alternative, novel and commercially viable process which has been developed for the preparation of Azilsartan, a pro-drug of Azilsartan medoxomil, an angiotensin II receptor blocker. The present work also provides a primary account of the synthesis and charact...

Full description

Bibliographic Details
Main Authors: Garaga Srinivas, Misra Nimesh C., Reddy Ambati V. Raghava, Prabahar Koilpillai Joseph, Takshinamoorthy Chandiran, Sanasi Paul Douglas, Korupolu Raghubabu
Format: Article
Language:English
Published: Sciendo 2015-06-01
Series:Current Issues in Pharmacy and Medical Sciences
Subjects:
Online Access:https://doi.org/10.1515/cipms-2015-0047
_version_ 1818728035885514752
author Garaga Srinivas
Misra Nimesh C.
Reddy Ambati V. Raghava
Prabahar Koilpillai Joseph
Takshinamoorthy Chandiran
Sanasi Paul Douglas
Korupolu Raghubabu
author_facet Garaga Srinivas
Misra Nimesh C.
Reddy Ambati V. Raghava
Prabahar Koilpillai Joseph
Takshinamoorthy Chandiran
Sanasi Paul Douglas
Korupolu Raghubabu
author_sort Garaga Srinivas
collection DOAJ
description This paper provides a description of an alternative, novel and commercially viable process which has been developed for the preparation of Azilsartan, a pro-drug of Azilsartan medoxomil, an angiotensin II receptor blocker. The present work also provides a primary account of the synthesis and characterization of the novel intermediates (6, 7 & 10) of Azilsartan, with their spectral data.
first_indexed 2024-12-17T22:23:36Z
format Article
id doaj.art-a5a6b47578fe4dceb2bc9172da4e1482
institution Directory Open Access Journal
issn 2084-980X
2300-6676
language English
last_indexed 2024-12-17T22:23:36Z
publishDate 2015-06-01
publisher Sciendo
record_format Article
series Current Issues in Pharmacy and Medical Sciences
spelling doaj.art-a5a6b47578fe4dceb2bc9172da4e14822022-12-21T21:30:25ZengSciendoCurrent Issues in Pharmacy and Medical Sciences2084-980X2300-66762015-06-01282727610.1515/cipms-2015-0047cipms-2015-0047An alternative synthesis of Azilsartan: an angiotensin II receptor blockerGaraga Srinivas0Misra Nimesh C.1Reddy Ambati V. Raghava2Prabahar Koilpillai Joseph3Takshinamoorthy Chandiran4Sanasi Paul Douglas5Korupolu Raghubabu6Chemical Research and Development Department, Aurobindo Pharma Ltd, Survey No: 71&72, Indrakaran Village, Sangareddy Mandal, Medak district, Hyderabad – 502329, Andhra Pradesh, IndiaChemical Research and Development Department, Aurobindo Pharma Ltd, Survey No: 71&72, Indrakaran Village, Sangareddy Mandal, Medak district, Hyderabad – 502329, Andhra Pradesh, IndiaChemical Research and Development Department, Aurobindo Pharma Ltd, Survey No: 71&72, Indrakaran Village, Sangareddy Mandal, Medak district, Hyderabad – 502329, Andhra Pradesh, IndiaChemical Research and Development Department, Aurobindo Pharma Ltd, Survey No: 71&72, Indrakaran Village, Sangareddy Mandal, Medak district, Hyderabad – 502329, Andhra Pradesh, IndiaChemical Research and Development Department, Aurobindo Pharma Ltd, Survey No: 71&72, Indrakaran Village, Sangareddy Mandal, Medak district, Hyderabad – 502329, Andhra Pradesh, IndiaDepartment of Engineering Chemistry, A. U. College of Engineering (A), Andhra University, Visakhapatnam – 530003, Andhra Pradesh, IndiaDepartment of Engineering Chemistry, A. U. College of Engineering (A), Andhra University, Visakhapatnam – 530003, Andhra Pradesh, IndiaThis paper provides a description of an alternative, novel and commercially viable process which has been developed for the preparation of Azilsartan, a pro-drug of Azilsartan medoxomil, an angiotensin II receptor blocker. The present work also provides a primary account of the synthesis and characterization of the novel intermediates (6, 7 & 10) of Azilsartan, with their spectral data.https://doi.org/10.1515/cipms-2015-0047azilsartannovel intermediatessynthesis and characterization
spellingShingle Garaga Srinivas
Misra Nimesh C.
Reddy Ambati V. Raghava
Prabahar Koilpillai Joseph
Takshinamoorthy Chandiran
Sanasi Paul Douglas
Korupolu Raghubabu
An alternative synthesis of Azilsartan: an angiotensin II receptor blocker
Current Issues in Pharmacy and Medical Sciences
azilsartan
novel intermediates
synthesis and characterization
title An alternative synthesis of Azilsartan: an angiotensin II receptor blocker
title_full An alternative synthesis of Azilsartan: an angiotensin II receptor blocker
title_fullStr An alternative synthesis of Azilsartan: an angiotensin II receptor blocker
title_full_unstemmed An alternative synthesis of Azilsartan: an angiotensin II receptor blocker
title_short An alternative synthesis of Azilsartan: an angiotensin II receptor blocker
title_sort alternative synthesis of azilsartan an angiotensin ii receptor blocker
topic azilsartan
novel intermediates
synthesis and characterization
url https://doi.org/10.1515/cipms-2015-0047
work_keys_str_mv AT garagasrinivas analternativesynthesisofazilsartananangiotensiniireceptorblocker
AT misranimeshc analternativesynthesisofazilsartananangiotensiniireceptorblocker
AT reddyambativraghava analternativesynthesisofazilsartananangiotensiniireceptorblocker
AT prabaharkoilpillaijoseph analternativesynthesisofazilsartananangiotensiniireceptorblocker
AT takshinamoorthychandiran analternativesynthesisofazilsartananangiotensiniireceptorblocker
AT sanasipauldouglas analternativesynthesisofazilsartananangiotensiniireceptorblocker
AT korupoluraghubabu analternativesynthesisofazilsartananangiotensiniireceptorblocker
AT garagasrinivas alternativesynthesisofazilsartananangiotensiniireceptorblocker
AT misranimeshc alternativesynthesisofazilsartananangiotensiniireceptorblocker
AT reddyambativraghava alternativesynthesisofazilsartananangiotensiniireceptorblocker
AT prabaharkoilpillaijoseph alternativesynthesisofazilsartananangiotensiniireceptorblocker
AT takshinamoorthychandiran alternativesynthesisofazilsartananangiotensiniireceptorblocker
AT sanasipauldouglas alternativesynthesisofazilsartananangiotensiniireceptorblocker
AT korupoluraghubabu alternativesynthesisofazilsartananangiotensiniireceptorblocker